Global Cord Blood Corp (NYSE:CO) was the recipient of a significant decline in short interest in June. As of June 15th, there was short interest totalling 401,000 shares, a decline of 7.8% from the May 15th total of 434,700 shares. Currently, 1.1% of the company’s shares are sold short. Based on an average trading volume of 50,800 shares, the short-interest ratio is currently 7.9 days.
CO stock traded down $0.03 during trading on Friday, hitting $5.82. 96,731 shares of the company’s stock traded hands, compared to its average volume of 78,803. The company has a market capitalization of $707.43 million, a price-to-earnings ratio of 16.63 and a beta of 0.26. The stock’s fifty day moving average price is $6.10. Global Cord Blood has a 1 year low of $4.82 and a 1 year high of $8.94.
A number of hedge funds have recently modified their holdings of the stock. Jayhawk Capital Management L.L.C. purchased a new position in Global Cord Blood in the first quarter worth $94,246,000. Norges Bank purchased a new position in Global Cord Blood in the fourth quarter worth $4,156,000. SG Americas Securities LLC purchased a new position in Global Cord Blood in the first quarter worth $758,000. Lingohr & Partner Asset Management GmbH purchased a new position in Global Cord Blood in the first quarter worth $422,000. Finally, BlackRock Inc. grew its holdings in Global Cord Blood by 2,935.0% in the fourth quarter. BlackRock Inc. now owns 7,284 shares of the medical research company’s stock worth $47,000 after purchasing an additional 7,044 shares during the last quarter. 17.06% of the stock is currently owned by institutional investors.
About Global Cord Blood
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.
Read More: What are municipal bonds?
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.